Clinical pathological conditions such as tumor node metastasis (TNM) stage, hormone receptor expression, human epidermal growth factor 2 (HER2) expression, and metastasis lead to different prognoses of breast cancer[2]. Here, ERBB2 is linked to breast carcinoma.